Quarterly report pursuant to Section 13 or 15(d)

Share-based Compensation (Tables)

v3.20.2
Share-based Compensation (Tables)
6 Months Ended
Sep. 30, 2020
Share-based Payment Arrangement [Abstract]  
Summary of Activity for Stock Options
The following table summarizes activity for stock options during the period ended September 30, 2020:
Number of Options
Weighted Average
Exercise Price
Weighted Average Remaining Contractual Term Aggregate Intrinsic Value
(in thousands) (per share) (years) (in thousands)
Balance, March 31, 2020 7,147  $ 16.26  9.3 $ 54,423 
Granted 2,229  33.37 
Exercised (302) 16.00 
Forfeited (237) 16.96 
Balance, September 30, 2020 8,837  $ 20.57  9.0 $ 180,799 
Options vested and exercisable at September 30, 2020 1,396  $ 16.05  8.8 $ 34,855 
Summary of Activity for Restricted Shares
The following table provides a summary of the changes in the number of restricted shares for the period ended September 30, 2020:
Number of Shares of
Restricted Stock Awards
Weighted Average
Grant Date Fair Value
Number of Restricted Stock Units Weighted Average
Grant Date Fair Value
(in thousands) (per share) (in thousands) (per share)
Balance, March 31, 2020 1,984  $ 16.00  3,123  $ 16.39 
Granted —  —  1,243  33.54 
Vested (848) 16.00  (806) 16.06 
Forfeited (96) 16.00  (118) 17.75 
Balance, September 30, 2020 1,040  $ 16.00  3,442  $ 22.62 
Schedule of Share-based Compensation Expense
The following table summarizes the components of total share-based compensation expense included in the condensed consolidated financial statements for each period presented (in thousands):
Three Months Ended September 30, Six Months Ended September 30,
2020 2019 2020 2019
Cost of revenue $ 1,866  $ 12,720  $ 3,364  $ 16,029 
Research and development 2,989  27,379  5,407  34,506 
Sales and marketing 6,122  56,781  11,527  71,885 
General and administrative 3,854  57,866  7,205  73,751 
Total share-based compensation expense $ 14,831  $ 154,746  $ 27,503  $ 196,171